Islay Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-62
Closed -$22.7K 248
2022
Q4
$22.7K Buy
62
+22
+55% +$7.8K 0.03% 165
2022
Q3
$13K Hold
40
0.02% 199
2022
Q2
$13K Hold
40
0.01% 225
2022
Q1
$11K Hold
40
0.01% 242
2021
Q4
$11K Buy
+40
New +$10.1K 0.01% 239

Other funds holding LLY

Islay Capital Management's LLY Position: Q1 2023 in Review

Islay Capital Management sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 62 shares — an estimated $22.7K sold.

Islay Capital Management first reported a position in LLY in Q4 2021 and held it in 5 quarters. The position peaked at $22.7K in Q4 2022. 2,614 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Islay Capital Management reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Islay Capital Management sold 62 Eli Lilly shares in Q1 2023, an estimated $22.7K.
  • Islay Capital Management first reported a position in Eli Lilly in Q4 2021 and held it in 5 quarters.
  • Islay Capital Management's Eli Lilly position peaked at $22.7K in Q4 2022.
  • 2,614 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Islay Capital Management's 13F filing for Q1 2023, filed 10 May 2023.